Does Nuvectis Pharma (NVCT) Have the Potential to Rally 108.79% as Wall Street Analysts Expect?

Nuvectis Pharma, Inc. (NVCT) closed the last trading session at $9.22, gaining 8.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 19.25 indicates a 108.8% upside potential.The mean estimate comprises four short-term price targets with a standard deviation of $4.35. While the lowest estimate of$ 15 indicates a 62.7% increase from the current price level, the most optimistic analy ...